domain | biospace.com |
summary | Eli Lilly has released a second Phase III trial for orforglipron, while AbbVie purchased Gilgamesh's depression asset for $1.2 billion, signifying their commitment to psychedelic therapeutics. In terms of COVID-19, Retsef Levi, a vaccine skeptic, has been appointed by the CDC as the leader of its COVID-19 immunization working group. The FDA is prioritizing overall survival in cancer drug development. |
title | BioSpace: Biotech, Pharmaceutical and Clinical Research News |
description | BioSpace: Biotech, Pharmaceutical and Clinical Research News |
keywords | read, august, tristan, companies, more, obesity, drug, report, insights, therapy, armstrong, life, gene, vaccines, weight, loss, market |
upstreams |
|
downstreams |
|
nslookup | A 15.197.236.53 |
created | 2025-08-05 |
updated | 2025-09-01 |
summarized | 2025-09-01 |
|
|